Jane Street
SPRY icon

Jane Street’s ARS Pharmaceuticals SPRY Stock Holding History

Jane Street’s Portfolio SPRY Stock Details SPRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$134K Buy
16,700
+4,000
+31% +$38.3K ﹤0.01% 10470
2025
Q4 		$148K Buy
+12,700
New +$124K ﹤0.01% 9940
2025
Q2 		– Sell
-39,300
Closed -$494K – 10810
2025
Q1 		$494K Buy
39,300
+14,400
+58% +$173K ﹤0.01% 6882
2024
Q4 		$263K Buy
+24,900
New +$349K ﹤0.01% 7952
2024
Q3 		– Sell
-190,200
Closed -$1.62M – 10359
2024
Q2 		$1.62M Buy
+190,200
New +$1.69M ﹤0.01% 4868

Other funds holding SPRY

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Jane Street's SPRY Position: Q4 2025 in Review

Jane Street sold out of ARS Pharmaceuticals (SPRY) in Q4 2025, closing a stake of 242,037 shares — an estimated $2.35M sold.

Jane Street first reported a position in SPRY in Q4 2020 and held it in 13 quarters. The position peaked at $2.43M in Q3 2025. 189 funds tracked by Wall St. Rank hold SPRY as of Q4 2025.

  • Jane Street reported no remaining ARS Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Jane Street sold 242,037 ARS Pharmaceuticals shares in Q4 2025, an estimated $2.35M.
  • Jane Street first reported a position in ARS Pharmaceuticals in Q4 2020 and held it in 13 quarters.
  • Jane Street's ARS Pharmaceuticals position peaked at $2.43M in Q3 2025.
  • 189 funds tracked by Wall St. Rank held ARS Pharmaceuticals as of Q4 2025.

Based on Jane Street's 13F filing for Q4 2025, filed 12 Feb 2026.